Related Experiment Video
Updated: Aug 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating
Jing Chen1,2,3, Qi Yin2,3, Shiheng Xu2
1Department of Pulmonary and Critical Care Medicine, Yunnan Provincial Key Laboratory for Clinical Virology, Institute of Basic and Clinical Medicine, The First People's Hospital of Yunnan Province, Kunming, China.
Background:
Studies revealed that exosomes from IFN-α-treated liver non-parenchymal cells (IFN-exo) mediate antiviral activity. MiR-106b-3p has been shown to play a paradoxical role in disease progressing from different studies. However, its specific role in HBV-related hepatocellular carcinoma (HBV-HCC) and the underlying mechanism remains unclear.
Method:
Huh7 cells transient transfected with plasmids of HBV-C2 and B3 were co-cultured with IFN-exo. Cell supernatants were collected to detect miR-106b-3p, HBsAg, HBeAg and HBV DNA levels. Cell proliferation, apoptosis, migration and invasion were analyzed. The putative targets of miR-106b-3p were identified by a dual-luciferase reporter system. The expression of PCGF3, migratory proteins(MMP2/9), and the PI3K/AKT signaling pathway-related proteins were assessed by western blot. The expression of PCGF3 mRNA was quantitative analyzed by using 52 pairs of paraffin-embedded tissues from HCC patients. siRNAs-PCGF3 were used to knocked-down PCGF3 expression.
Results:
The expression of miR-106b-3p was significantly higher in THP-1 cells and supernatants treated with IFN-exo than those untreated. Significantly increased expression of miR-106b-3p and decreased expression of HBsAg and HBV DNA were observed in Huh7-C2/B3 cells treated with IFN-exo. In addition, miR-106b-3p was directly target to PCGF3. Scratch healing assay and transwell assay showed that either IFN-exo or miRNA-106-3p over-expression, or siRNAs-PCGF3 inhibited migration and invasion of Huh7-C2/B3 cells, and subsequently resulted in suppression of p-AKT/AKT and p-PI3K/PI3K. Notably, the expression level of PCGF3 was significantly lower in HBeAg (+)-HCC tumor tissues than HBeAg (-)-HCC tumor.
Conclusion:
IFN-α-induced macrophage-derived miR-106b-3p inhibits HBV replication, HBV- Huh7 cells migration and invasion via regulating PCGF3/PI3K/AKT signaling axis. miR-106b-3p and PCGF3 were potential biomarkers in the prevention and treatment of HBV-HCC.
Insights
Interferon-alpha-induced exosomes (IFN-exo) deliver miR-106b-3p, which inhibits hepatitis B virus (HBV) replication and hepatocellular carcinoma (HCC) cell migration by targeting PCGF3. This miR-106b-3p/PCGF3 axis offers potential biomarkers for HBV-HCC prevention and treatment.
Area of Science:
- Hepatology
- Molecular Biology
- Oncology
Background:
- Exosomes derived from interferon-alpha-treated liver non-parenchymal cells (IFN-exo) exhibit antiviral properties.
- The role of miR-106b-3p in hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) and its underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of miR-106b-3p delivered by IFN-exo in HBV-HCC.
- To elucidate the mechanism by which miR-106b-3p affects HBV replication and HCC progression.
Main Methods:
- Huh7 cells (HBV-C2 and B3 transfected) were co-cultured with IFN-exo.
- miR-106b-3p, HBsAg, HBeAg, and HBV DNA levels were measured.
- Cell proliferation, apoptosis, migration, and invasion were analyzed.
- Dual-luciferase reporter assay identified PCGF3 as a direct target of miR-106b-3p.
- Western blot assessed protein expression related to PCGF3 and the PI3K/AKT pathway.
- PCGF3 mRNA expression was analyzed in HCC patient tissues.
Main Results:
- IFN-exo treatment significantly increased miR-106b-3p expression in cells and supernatants.
- miR-106b-3p overexpression in Huh7-C2/B3 cells reduced HBsAg and HBV DNA levels.
- miR-106b-3p directly targets and downregulates PCGF3 expression.
- IFN-exo, miR-106b-3p, or siRNAs-PCGF3 inhibited cell migration and invasion, suppressing the PI3K/AKT pathway.
- PCGF3 expression was lower in HBeAg-positive HCC tissues compared to HBeAg-negative tissues.
Conclusions:
- Macrophage-derived miR-106b-3p delivered by IFN-exo inhibits HBV replication and HCC cell migration/invasion by regulating the PCGF3/PI3K/AKT signaling axis.
- miR-106b-3p and PCGF3 are potential biomarkers for the prevention and treatment of HBV-HCC.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Hepatitis
Inhibitors of Viral Protein Synthesis